expert insights
In-depth showcase: Targeted therapies are transforming blood cancer care. So why aren’t they reaching every patient?
Jeff Bergen, Scientific Director, Medical; Maddi Davidson, Principal, Advisory; Brian Gillespie, Managing Director, Advisory; Kolton Gustafson, Principal, Advisory; Jahda Hill, Senior Vice President, Medical and Scientific Affairs, Marketing; Jessica Holzhauer, Director, Scientific Strategy, Medical; Clare Jones, Executive Director, Global Market Access, Advisory; Victoria Shea, Vice President, Brand Strategy, Marketing | May 19, 2026
Hematology-oncology
The blood cancer landscape is filled with transformative therapies…. and the nagging sense that for too many patients, these treatments are just out of reach. Somewhere between approval and the treatment chair, patients are falling through the cracks. This report explores why – and what you can do about it.
Hemato-oncology is living through its most extraordinary moment. CAR-T therapies, bispecific antibodies, and emerging trispecific platforms are rewriting what’s possible for patients with blood cancer. And yet three out of four oncologists say they’re overwhelmed by the pace of innovation, and 73% of healthcare professionals report a gap between treatment availability and successful use in clinical practice.
‘Hematology-oncology in focus’ is Avalere Health’s flagship showcase report. It examines why targeted hemato-oncology treatments aren’t reaching every eligible patient and what the biopharmaceutical industry must do differently to close the gap.
What’s inside
A deep dive into the tensions holding patients back
This showcase examines the interconnected forces – scientific, systemic, and societal – that determine whether a breakthrough treatment reaches the patient who needs it. Across four chapters, we go beyond the data to reveal what it will take to drive change, ensuring more patients benefit from life-changing blood cancer treatments.
Part I: Scientific Barriers | The blood cancer landscape is evolving at lightning speed. We examine why healthcare professionals are struggling to keep pace and how brands can turn complexity into clarity to drive referrals in the community.
Part II: Systemic Challenges | Geography, time, coverage, and infrastructure — we explore the structural forces that stall the journey from referral to treatment, and what it costs patients when the system fails.
Part III: Societal Impact | From psychological burden to caregiver strain to stark racial and socioeconomic disparities, we examine what it truly means to live with blood cancer in America today.
Part IV: Five Strategic Imperatives | Practical, integrated strategies for reaching every patient possible.
Patient stories told by those living it
This report is grounded in the voices of real patients — Bob, Carol, and Kerry — whose journeys illuminate the human cost of every gap. Their stories sit alongside expert perspectives from Avalere Health’s Advisory, Medical, and Marketing oncology specialists, uniting lived experience with strategic insight.
Download the free report
Ready to bring every patient possible within reach?
Closing the gap between innovation and access demands a deep understanding of science, systems, and society – the barriers, opportunities, and where these forces collide. Book a SenseMaking landscape consultation with Avalere Health’s hemato-oncology experts. Reveal the tensions holding your therapies back, and the opportunities your competitors haven’t found yet.